MARKETSBiogen Shares Rise After ‘Best-Case’ Alzheimer’s Drug Trial ResultsAniruddh ShrivastavaSeptember 28, 2022September 28, 2022 by Aniruddh ShrivastavaSeptember 28, 2022September 28, 202201909 On Wednesday, shares of Biogen (NASDAQ:BIIB) are trading sharply higher in pre-market as the company has announced positive topline results for its experimental Alzheimer’s drug....